This request estimated use of dolutegravir among women of reproductive age and those with a prior human immunodeficiency virus (HIV) diagnosis in the Sentinel Distributed Database (SDD). This request also examined dolutegravir use during pregnancy among women with live-birth deliveries in the SDD.
Data from August 1, 2013 to March 31, 2018 from 16 Data Partners contributing to the SDD were included in the report. This request was distributed to Data Partners on August 21, 2018.
Deliverables (1)Sentinel Modular Program Report: Dolutegravir Use During Pregnancy